OMERACT 系统性红斑狼疮领域调查
该研究邀请多伦多大学狼疮诊所的100例系统性红斑狼疮患者和145名OMERACT系统性红斑狼疮工作组成员完成调查,评估候选领域重要性并征集新领域。患者倾向于优先考虑生活影响领域,而合作者优先考虑临床领域,两组均推荐在1998年核心结果集和研究议程之外增加新领域。
要点
- 患者倾向于优先考虑生活影响领域,合作者优先考虑临床领域。
- 患者和合作者均推荐在1998年系统性红斑狼疮核心结果集和研究议程之外增加领域。
- 研究识别出对可能纳入核心结果集已有高度一致的领域、需要进一步解释的领域以及值得考虑的新领域。
核心结论
- 患者和合作者优先考虑的领域不同,因此纳入两组观点对于确保系统性红斑狼疮的全面评估至关重要。
研究设计与样本
- OMERACT系统性红斑狼疮工作组指导委员会开发了一项调查,邀请多伦多大学狼疮诊所随访的系统性红斑狼疮患者(患者组)和OMERACT系统性红斑狼疮工作组成员(合作者组)于2022年8月至2023年2月完成。
主要发现
- 共邀请175例患者,100例完成调查;共邀请178名合作者,145名完成调查。
- 患者倾向于优先考虑生活影响领域,而合作者优先考虑临床领域。
- 患者和合作者均推荐在1998年系统性红斑狼疮核心结果集和研究议程所包含的领域之外增加领域。
关键数值与推荐
- 研究识别出对可能纳入系统性红斑狼疮核心结果集已有高度一致的领域、需要进一步解释的领域以及值得考虑的新领域。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Since the development of the OMERACT Systemic Lupus Erythematosus (SLE) Core Outcome Set (COS) in 1998, many new SLE domains have been identified and measures developed, creating a need to update the SLE COS. To revisit the 1998 SLE COS and research agenda domains, and generate new candidate domains, we conducted this study of patients with SLE and collaborators. OBJECTIVE: (1) To evaluate existing candidate SLE domains for inclusion in the SLE COS. (2) To generate additional candidate SLE domains for COS consideration. (3) To engage SLE collaborators, including patients, in developing the updated SLE COS. METHODS: The OMERACT SLE Working Group's steering committee developed a survey to assess the importance of candidate SLE domains and generate additional domains for consideration towards the SLE COS. Patients with SLE followed at the University of Toronto Lupus Clinic (patient group) and members of the OMERACT SLE Working Group (collaborator group) were invited to complete the survey between August 2022 and February 2023. RESULTS: A total of 175 patients were invited and 100 completed the survey. Of 178 collaborators invited, 145 completed the survey. Patients tended to prioritize life-impact domains while collaborators prioritized clinical domains. Both patients and collaborators recommended additional domains to those included in the 1998 SLE COS and research agenda. CONCLUSION: The domain inclusion and importance results demonstrate that patients and collaborators prioritize different domains, so capturing the perspectives of both groups is essential to ensure a holistic assessment of SLE. The results of the study identify domains that already have a high level of agreement for potential inclusion in the SLE COS, domains that require further explanation, and novel domains that warrant consideration.
引用
- Nielsen W, Strand V, Simon L, et al. OMERACT systemic lupus erythematosus domain survey. Semin Arthritis Rheum. 2024. PMID: 39106780. doi:10.1016/j.semarthrit.2024.152520
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。